News & Blog

Press Release: Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

FAntastic Meeting Recap

2026 Cure FA Soirée Recap

Webinar Recording: Lexeo Therapeutics May 2026

Press Release & Community Statement: Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

Press Release: Update from Lexeo Therapeutics

Meet The Community: Deborah Medford

May/June 2026 – Advocacy Newsletter

Webinar Recording: Solid Biosciences May 2026

Meet The Community: Kadence Foley

Community Letter: Update from PTC Therapeutics

Meet The Community: Carly Stinson